C

Cyclacel Pharmaceuticals
D

CYCC

0.35000
USD
-0.00
(-1.38%)
مغلق
حجم التداول
14,343
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
3,939,647
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AVXL
    0.230
    (2.30%)
    10.230 USD
    C
    CLRB
    -0.00420
    (-1.71%)
    0.24100 USD
    D
    DCTH
    0.920
    (6.04%)
    16.160 USD
    P
    PTN
    -0.01690
    (-1.74%)
    0.95310 USD
    S
    SLS
    -0.15500
    (-13.60%)
    0.98500 USD
    المزيد
الأخبار
المقالات

العنوان: Cyclacel Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.